The estimated Net Worth of Christine A Poon is at least $15.6 Milion dollars as of 15 August 2024. Ms. Poon owns over 10,838 units of Regeneron Pharmaceuticals stock worth over $14,850,265 and over the last 21 years she sold REGN stock worth over $0. In addition, she makes $719,993 as Independent Director at Regeneron Pharmaceuticals.
Christine has made over 15 trades of the Regeneron Pharmaceuticals stock since 2014, according to the Form 4 filled with the SEC. Most recently she exercised 10,838 units of REGN stock worth $4,479,671 on 15 August 2024.
The largest trade she's ever made was exercising 40,000 units of Regeneron Pharmaceuticals stock on 28 August 2020 worth over $1,137,600. On average, Christine trades about 690 units every 24 days since 2003. As of 15 August 2024 she still owns at least 13,010 units of Regeneron Pharmaceuticals stock.
You can see the complete history of Ms. Poon stock trades at the bottom of the page.
Christine A. Poon serves as Independent Director of the Company. She is an Executive-in-Residence in the Department of Management and Human Resources at The Max M. Fisher College of Business at The Ohio State University, where she served as Dean and the John W. Berry, Sr. Chair in Business from 2009 to 2014. Prior to joining Fisher, Ms. Poon spent eight years at Johnson & Johnson, most recently as vice chairman and worldwide chairman of pharmaceuticals. At Johnson & Johnson, she served on the company’s board of directors and executive committee and was responsible for managing the pharmaceutical businesses of the company. Prior to joining Johnson & Johnson, Ms. Poon spent 15 years at Bristol-Myers Squibb Company, a global pharmaceutical company, where she held senior leadership positions including president of international medicines and president of medical devices. Ms. Poon serves on the boards of directors of Prudential Financial, Inc. and The Sherwin-Williams Company and the Supervisory Board of Royal Philips Electronics. Ms. Poon’s extensive expertise in domestic and international business operations, including sales and marketing and commercial operations, and her deep strategic and operational knowledge of the pharmaceutical industry, led to the board’s decision to nominate Ms. Poon for reelection to the board.
As the Independent Director of Regeneron Pharmaceuticals, the total compensation of Christine Poon at Regeneron Pharmaceuticals is $719,993. There are 17 executives at Regeneron Pharmaceuticals getting paid more, with P. Roy Vagelos having the highest compensation of $22,304,300.
Christine Poon is 68, she's been the Independent Director of Regeneron Pharmaceuticals since 2010. There are 3 older and 20 younger executives at Regeneron Pharmaceuticals. The oldest executive at Regeneron Pharmaceuticals, Inc. is P. Roy Vagelos, 90, who is the Chairman of the Board, Director.
Over the last 22 years, insiders at Regeneron Pharmaceuticals have traded over $13,084,686,326 worth of Regeneron Pharmaceuticals stock and bought 8,562,481 units worth $2,539,854,760 . The most active insiders traders include Sanofi, Pharma Ag Novartis oraz Leonard S Schleifer. On average, Regeneron Pharmaceuticals executives and independent directors trade stock every 8 days with the average trade being worth of $47,694,347. The most recent stock trade was executed by Marion Mc Court on 3 September 2024, trading 1,000 units of REGN stock currently worth $381,400.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Regeneron Pharmaceuticals executives and other stock owners filed with the SEC include: